Destiny Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
CA
Destiny Wealth Partners's BME Position: Q1 2023 in Review
Destiny Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 1 share — an estimated $31 sold.
Destiny Wealth Partners first reported a position in BME in Q3 2022 and held it in 2 quarters. The position peaked at $137K in Q3 2022. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.
- Destiny Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
- Destiny Wealth Partners sold 1 BlackRock Health Sciences Trust share in Q1 2023, an estimated $31.
- Destiny Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q3 2022 and held it in 2 quarters.
- Destiny Wealth Partners's BlackRock Health Sciences Trust position peaked at $137K in Q3 2022.
- 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.
Based on Destiny Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.